Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Traditional Chinese medicine composition for preventing restenosis after percutaneous coronary intervention

A coronary artery and restenosis technology, applied in the field of traditional Chinese medicine, can solve the problems of drug stenosis and other problems, achieve the effect of reducing restenosis, improving the quality of life, and good patient compliance

Inactive Publication Date: 2016-05-18
刘元梅
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although people continue to apply new drugs and new technology methods to clinical practice, there is still no ideal drug to prevent restenosis.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese medicine composition for preventing restenosis after percutaneous coronary intervention

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] A traditional Chinese medicine composition for preventing restenosis after coronary artery stent operation, which is composed of 9 grams of sumac, 6 grams of valerian, 4 grams of Chinese rose, 15 grams of pangolin, 4 grams of pomelo flower, 15 grams of sage vine, and 30 grams of motherwort , 20 grams of Forsythia, 12 grams of Geshanxiao, and 10 grams of Tujianqi are made into water decoction according to conventional Chinese medicine preparation technology, one dose per person per day.

Embodiment 2

[0039] A traditional Chinese medicine composition for preventing restenosis after coronary artery stent operation, which is composed of 6 grams of sumac, 5 grams of valerian, 3 grams of rose flower, 12 grams of pangolin, 3 grams of pomelo flower, 12 grams of sage vine, and 20 grams of motherwort , 15 grams of Forsythia, 10 grams of Geshanxiao, and 8 parts of Tujianqi are made into water decoction according to conventional Chinese medicine preparation technology, one dose per person per day.

Embodiment 3

[0041] A traditional Chinese medicine composition for preventing restenosis after coronary artery stent operation, which is composed of 3 grams of sumac, 4 grams of valerian, 2 grams of Chinese rose, 9 grams of pangolin, 2 grams of pomelo flower, 9 grams of Rhododendron, and 10 grams of Motherwort , Forsythia 10 grams, Geshanxiao 8 grams, and Tujianqi 6 grams are made into water decoction according to conventional Chinese medicine preparation technology, one dose per person per day.

[0042] The traditional Chinese medicine composition in the embodiment 1~3 can also be prepared into honeyed pills, concentrated water honeyed pills, watered pills, granules, capsules, tablets, powders, ointment, oral liquid. Its effect is the same as that of water decoction.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a traditional Chinese medicine composition for preventing restenosis after percutaneous coronary intervention. The traditional Chinese medicine preparation is prepared from the following raw medicines: sapanwood, valerian, Chinese rose, dioscorea nipponica, pummelo flower, sargentg loryvine, motherwort, forsythia, auriculate swallowwort root and longflower stringbush root. The traditional Chinese medicine composition for preventing restenosis after percutaneous coronary intervention, provided by the invention, is capable of reducing the death rate, relieving symptoms, reducing restenosis occurrence, improving the life quality of patients, reducing the treatment cost and ensuring that the patient dependence is good. By adopting a water decoction of the traditional Chinese medicine composition for preventing restenosis after percutaneous coronary intervention, provided by the invention, for treating 40 patients for six months, the restenosis rate of a treatment group is 12.50%, and the restenosis rate of a control group is 32.50%, so that the restenosis rate of the treatment group is obviously lower than the restenosis rate of the control group, wherein P is less than 0.05.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine composition for preventing restenosis after coronary artery stenting. Background technique [0002] Coronary artery stent implantation has become the main means of interventional treatment of coronary heart disease. The application of intracoronary stents reduces the rate of restenosis after coronary intervention to less than 30%, but the treatment of restenosis in stents is still a difficult problem. Although people continue to apply new drugs and new technologies to clinical practice, there is still no ideal drug to prevent restenosis. Seeking traditional Chinese medicine to prevent restenosis after coronary artery stenting has become a research hotspot. The present inventor draws on the mature experience of treating coronary heart disease with traditional Chinese medicine, analyzes the pathogenesis of traditional Chinese me...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8945A61P9/10
CPCA61K36/48A61K9/0095A61K36/185A61K36/27A61K36/533A61K36/634A61K36/738A61K36/752A61K36/83A61K36/84A61K36/8945A61K2300/00
Inventor 刘元梅张英杰唐树杰
Owner 刘元梅
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products